1. Application of Zizao Yangrong Granules for Treating Targeted Drugs–Related Skin Xerosis: A Randomized Double-Blinded Controlled Study. (June 2020) Authors: Peng, Yan Mei; Duan, Hua; Zhang, Jingyi; Sun, Chenyao; Zhang, Xu; Shen, Wen; Zheng, Shuyue; Tan, Kexin; Jiang, Xuejiao; Li, Jia; Cui, Hui Juan Journal: Integrative cancer therapies Issue: Volume 19(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes of IL-6 And IFN-γ before and after the adverse events related to immune checkpoint inhibitors: A retrospective study. Issue 46 (18th November 2022) Authors: Zhang, Xu; Lu, Xingyu; Yu, Yixuan; Tan, Kexin; Cui, Huijuan Journal: Medicine Issue: Volume 101:Issue 46(2022) Page Start: e31761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis. (7th January 2023) Authors: Dong, Huijing; Xue, Chongxiang; Zheng, Yumin; Zhang, Xu; Hu, Zixin; Lu, Xingyu; Yu, Yixuan; Li, Jia; Tan, Kexin; Cui, Huijuan Other Names: Granito Alessandro Academic Editor. Journal: Journal of oncology Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hyper-Methylated Hub Genes of T-Cell Receptor Signaling Predict a Poor Clinical Outcome in Lung Adenocarcinoma. (6th April 2022) Authors: Hu, Zixin; Xue, Chongxiang; Zheng, Jiabin; Lu, Xingyu; Li, Jia; Dong, Huijing; Yu, Yixuan; Zhang, Xu; Tan, Kexin; Cui, Huijuan Other Names: Jiang Feng Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Simulated ENSO's impact on tropical cyclone genesis over the western North Pacific in CMIP5 models and its changes under global warming. (3rd March 2019) Authors: Tan, Kexin; Huang, Ping; Liu, Fei; Murakami, Hiroyuki; Hsu, Pang‐chi Journal: International journal of climatology Issue: Volume 39:Number 8(2019) Page Start: 3668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The incidence of pseudoprogressive disease associated with programmed cell death 1/programmed cell death ligand 1 inhibitors: A meta-analysis. Issue 28 (16th July 2021) Authors: Zhang, Jingyi; Tan, Kexin; Jiang, Xuejiao; Zheng, Shuyue; Li, Jia; Xue, Chongxiang; Zhang, Xu; Cui, Huijuan Other Names: Saranathan. Maya section editor. Journal: Medicine Issue: Volume 100:Issue 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topical Zhiyang Pingfu Liquid for Moderate to Severe Skin Rash Associated With EGFRIs: A double-blinded randomized controlled trial. (November 2022) Authors: Zhang, Jingyi; Lu, Xingyu; Zhang, Xu; Tan, Kexin; Li, Jia; Cui, Huijuan Journal: Integrative cancer therapies Issue: Volume 21(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Tuning d‐Band Center of Pt by PtCo‐PtSn Heterostructure for Enhanced Oxygen Reduction Reaction Performance. Issue 12 (22nd January 2022) Authors: Chen, Jinli; Qian, Guangfu; Chu, Bingxian; Jiang, Zexing; Tan, Kexin; Luo, Lin; Li, Bin; Yin, Shibin Journal: Small Issue: Volume 18:Issue 12(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗